Lundbeck
HLUN-B.CO
#2582
Rank
HK$41.78 B
Marketcap
HK$43.84
Share price
-0.98%
Change (1 day)
18.19%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total debt

Total debt on the balance sheet as of September 2024 : HK$4.87 Billion

According to Lundbeck 's latest financial reports the company's total debt is HK$4.87 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Lundbeck - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31HK$4.80 B-23.51%
2022-12-31HK$6.27 B-0.65%
2021-12-31HK$6.31 B-37.51%
2020-12-31HK$10.11 B-9.6%
2019-12-31HK$11.18 B
2018-12-31N/A-100%
2017-12-31HK$71.79 M-96.55%
2016-12-31HK$2.08 B-51.39%
2015-12-31HK$4.28 B1.11%
2014-12-31HK$4.23 B36.57%
2013-12-31HK$3.10 B18.19%
2012-12-31HK$2.62 B1%
2011-12-31HK$2.59 B-3.08%
2010-12-31HK$2.68 B-48.36%
2009-12-31HK$5.19 B87.86%
2008-12-31HK$2.76 B-2.85%
2007-12-31HK$2.84 B43.91%
2006-12-31HK$1.97 B319.29%
2005-12-31HK$0.47 B-18.81%
2004-12-31HK$0.58 B